CD4 and cancer: Further, in epithelioid MMs, a CD4+/CD8+ ratio >1 and a high frequency of CD4+ T cells were associated with an improved survival, consistent with CD4+ T lymphocytes’ role in the stimulation of CD8+ TILS and B-cells against cancer cells.